Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M100,585Revenue $M34,858Net Margin (%)44.2Altman Z-Score2.0
Enterprise Value $M118,570EPS $1.7Operating Margin %51.0Piotroski F-Score6
P/E(ttm)6.3Beneish M-Score-2.0Pre-tax Margin (%)52.1Higher ROA y-yY
Price/Book8.610-y EBITDA Growth Rate %0.5Quick Ratio1.0Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %-5.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow22.5y-y EBITDA Growth Rate %62.7ROA % (ttm)23.4Higher Current Ratio y-yY
Dividend Yield %6.1PEG--ROE % (ttm)173Less Shares Outstanding y-yY
Payout Ratio %38.0Shares Outstanding M2,415ROIC % (ttm)53.3Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKCharles Brandes 2015-03-31 Add0.38%$41.68 - $48.81
($45.86)
$ 41.65-9%Add 18.20%3,879,073
GSKNWQ Managers 2015-03-31 Add0.14%$41.68 - $48.81
($45.86)
$ 41.65-9%Add 123.03%456,380
GSKKahn Brothers 2015-03-31 Add0.06%$41.68 - $48.81
($45.86)
$ 41.65-9%Add 14.12%58,200
GSKDodge & Cox 2015-03-31 Reduce-0.02%$41.68 - $48.81
($45.86)
$ 41.65-9%Reduce 2.18%23,436,551
GSKHOTCHKIS & WILEY 2015-03-31 Add0.01%$41.68 - $48.81
($45.86)
$ 41.65-9%Add 0.73%12,302,975
GSKJoel Greenblatt 2015-03-31 Add$41.68 - $48.81
($45.86)
$ 41.65-9%Add 0.41%83,578
GSKKen Fisher 2015-03-31 Reduce$41.68 - $48.81
($45.86)
$ 41.65-9%Reduce 0.07%10,757,080
GSKTweedy Browne 2015-03-31 Reduce$41.68 - $48.81
($45.86)
$ 41.65-9%Reduce 2.19%131,346
GSKDodge & Cox 2014-12-31 Reduce-0.64%$41.3 - $47.14
($44.76)
$ 41.65-7%Reduce 37.91%23,959,301
GSKHOTCHKIS & WILEY 2014-12-31 Add0.21%$41.3 - $47.14
($44.76)
$ 41.65-7%Add 13.04%12,213,885
GSKDavid Dreman 2014-12-31 Sold Out -0.01%$41.3 - $47.14
($44.77)
$ 41.65-7%Sold Out0
GSKDodge & Cox 2014-09-30 Reduce-1.11%$46.29 - $54.52
($49.01)
$ 41.65-15%Reduce 35.93%38,589,161
GSKHOTCHKIS & WILEY 2014-09-30 Add0.98%$46.29 - $54.52
($49.01)
$ 41.65-15%Add 118.31%10,804,564
GSKCharles Brandes 2014-09-30 Add0.56%$46.29 - $54.52
($49.01)
$ 41.65-15%Add 36.63%3,415,717
GSKKahn Brothers 2014-09-30 Buy 0.38%$46.29 - $54.52
($49.01)
$ 41.65-15%New holding51,000
GSKNWQ Managers 2014-09-30 Add0.03%$46.29 - $54.52
($49.01)
$ 41.65-15%Add 39.82%208,125
GSKDavid Dreman 2014-09-30 Buy 0.01%$46.29 - $54.52
($49.01)
$ 41.65-15%New holding1,328
GSKHOTCHKIS & WILEY 2014-06-30 Add0.93%$51.55 - $56.39
($54.16)
$ 41.65-23%Add 13358.60%4,949,118
GSKJohn Rogers 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 41.65-23%Add 49.33%988,772
GSKCharles Brandes 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 41.65-23%Add 15.52%2,500,048
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2289.27view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.1496.97view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29687.15view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12247view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14197.43view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12247view

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    JW1 Jun 29 2015 
    JW1 Jun 28 2015 
    JW1 Jun 28 2015 
    JW1 Jun 28 2015 
    Weekly 3-Year Low Highlights: GSK, TRP, NOV, CHK Jun 15 2015 
    Guru Stocks at 52-Week Lows: XOM, WMT, PG, CVX, GSK Jun 14 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Hotchkis & Wiley Large Cap Value Fund Q1 2015 Commentary May 22 2015 
    Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer May 22 2015 
    9 International Dividend Dogs With Upside Potential May 22 2015 

    More From Other Websites
    Pfizer to buy two vaccines from Glaxo Jun 22 2015
    Regulatory update on divestment of Nimenrix and Mencevax Jun 22 2015
    UK investigator says Chinese officials mistreated him to get GSK confession Jun 18 2015
    China deports British, American investigators linked to GSK scandal Jun 17 2015
    GSK invests $95 million in effort to demystify cell 'operating system' Jun 16 2015
    Dementia drug developer Axovant climbs after $315M IPO Jun 11 2015
    Biotech’s Latest Miracle Drug Jun 09 2015
    Cervical cancer vaccine might work after just 1 shot, not 3 Jun 09 2015
    Cervical cancer vaccine might work after just 1 shot, not 3 Jun 09 2015
    One dose of cervical cancer vaccine may suffice, scientists say Jun 09 2015
    GlaxoSmithKline investigator 'released early from Chinese prison' Jun 09 2015
    GSK-linked investigator freed early from China jail - source Jun 09 2015
    GSK-linked investigator to be freed early from China prison - source Jun 09 2015
    Inside the Hedge Fund Club Pitching a New Alzheimer's Drug IPO Jun 08 2015
    Pharma Showdown: Should You Buy GlaxoSmithKline plc Or Shire PLC Jun 08 2015
    BP plc vs GlaxoSmithKline plc: Which Is The King Of The FTSE 100? Jun 05 2015
    GlaxoSmithKline downgraded by Morgan Stanley Jun 04 2015
    Is GlaxoSmithKline plc Making A Mistake By Prioritising The Dividend? Jun 04 2015
    Perrigo to Buy OTC Brands from GlaxoSmithKline in Europe - Analyst Blog Jun 03 2015
    Should You Invest In These 5%+ Yielders? Anglo American plc, GlaxoSmithKline plc, Telecom Plus PLC &... Jun 03 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK